American Vanguard Corp (AVD) 10.97 $AVD American

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Vanguard Corp (AVD) 10.97 $AVD

American Vanguard Schedules 2015 First Quarter Earnings Release and Conference Call for Thursday, April 30TH
Business Wire - Wed Apr 22, 8:00AM CDT
American Vanguard Corporation (NYSE:AVD), today announced that it will report financial results for the first quarter of 2015 on Thursday, April 30, 2015 after the close of the stock market. Details regarding the conference call appear below.
AVD: 10.97 (-0.51)

NYSE stocks posting largest percentage decreases
AP - Fri Apr 17, 5:13PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
W: 32.32 (-0.28), AVD: 10.97 (-0.51), BCEI: 24.50 (-0.20), MTW: 19.99 (+0.39), ATW: 29.26 (-0.12)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
VNET: 20.01 (+0.01), AMCN: 4.43 (+0.44), AMBR: 9.05 (-0.37), AVD: 10.97 (-0.51), ANDE: 43.46 (+0.76)

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
HIVE: 5.31 (+0.11), AMBR: 9.05 (-0.37), AVD: 10.97 (-0.51), ATRC: 21.31 (-0.36), ATEN: 4.72 (-0.01)

American Vanguard Snaps Up European Nemacur Assets - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 1:40PM CDT
American Vanguard (AVD) has purchased the European Nemacur assets of Adama Agricultural Solutions.
KMG: 30.00 (+1.28), AVD: 10.97 (-0.51), MTX: 68.84 (-1.34), OMG: 30.68 (+0.09)

American Vanguard buys Nemacur Nematicide Assets in Europe for undisclosed fee
M2 - Tue Apr 07, 4:44AM CDT
Agricultural company American Vanguard (NYSE:AVD) revealed on Monday that it has completed the acquisition of the European Nemacur insecticide/nematicide business assets for an undisclosed value.
AVD: 10.97 (-0.51)

Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 06, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
HIVE: 5.31 (+0.11), AMBR: 9.05 (-0.37), AVD: 10.97 (-0.51), ATEN: 4.72 (-0.01), MT: 9.63 (+0.22)

American Vanguard Acquires Nemacur(R) Nematicide Assets in Europe
Business Wire - Mon Apr 06, 8:00AM CDT
American Vanguard Corporation (NYSE:AVD), through its international subsidiary AMVAC Netherlands B.V., today announced the acquisition of Adama Agricultural Solutions Ltd.'s European Nemacur(R) insecticide/nematicide business assets. Financial terms of the agreement were not disclosed.
ADAM: (), AVD: 10.97 (-0.51)

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
VNET: 20.01 (+0.01), CALX: 8.48 (-0.07), AVD: 10.97 (-0.51), BIOS: 5.23 (+0.04), CBNK: 16.51 (-0.29)

American Vanguard to pay dividend to holders of record of 3 April 2015
M2 - Tue Mar 17, 5:27AM CDT
The board of directors of American Vanguard (NYSE:AVD), an agricultural company, on Monday declared dividend of USD0.02 of the company's stock.
AVD: 10.97 (-0.51)

American Vanguard declares $0.02 dividend
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 7:43AM CDT

AVD: 10.97 (-0.51)

American Vanguard Declares Quarterly Dividend
Business Wire - Mon Mar 16, 6:30AM CDT
American Vanguard Corp. (NYSE:AVD) announced that its Board of Directors has declared a $0.02 cash dividend payment to be distributed on April 17, 2015 to shareholders of record as of April 3, 2015.
AVD: 10.97 (-0.51)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 11:45AM CDT

BOX: 18.29 (+0.37), CMTL: 30.97 (+0.12), PTX: 7.44 (-0.05), PGEM: 14.26 (+0.15), AMRN: 2.34 (-0.05), AXN: 1.77 (+0.01), AAMC: 223.83 (-3.57), MEIL: 1.14 (-0.06), ECTE: 1.66 (+0.07), ACAD: 38.55 (-0.20), OME: 13.12 (+0.18), PQ: 2.54 (+0.02), BONT: 7.05 (-0.17), AVD: 10.97 (-0.51), BVX: 3.25 (+0.40), TISA: 3.39 (-0.01), SCLN: 8.99 (+0.04), ENRJ: 1.75 (+0.05), SPP: 2.14 (+0.07), CUR: 1.96 (-0.04)

American Vanguard upgraded to Buy from Hold at Topeka Capital
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 10:58AM CDT

AVD: 10.97 (-0.51)

Upgrade Alert for American Vanguard (AVD)
Comtex SmarTrend(R) - Thu Mar 12, 7:07AM CDT
American Vanguard (NYSE:AVD) was upgraded from Hold to Buy at Topeka today. The stock closed yesterday at $9.90 on volume of 265,000 shares, above average daily volume of 155,000. In the past 52 weeks, American Vanguard share prices have been bracketed by a low of $9.50 and a high of $22.20 and closed yesterday at $9.90, 4% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 0.8%.
AVD: 10.97 (-0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 9

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 301

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 359

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 536

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 15

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 268

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kodiak Gas Services: Anticipating Strong Earnings Results

Updated Category News Views 169

Kodiak Gas Services: Anticipating Strong Earnings Results Kodiak Gas Services (NYSE: KGS) is on the verge of announcing its quarterly earnings. Investors are keen to gain insights into potential performance as the company prepares for its report. Analysts are projecting an earnings per share (EPS) of $0.51, heightening expectations for this upcoming announcement....

Continue Reading
Anna Shlimak Steps Up as CFO to Propel Cronos Forward

Updated Category News Views 186

Anna Shlimak Steps into CFO Role at Cronos Group Inc. Cronos Group Inc. (NASDAQ: CRON), a leading name in the cannabinoid sector, has recently announced a significant shift in its executive team with Anna Shlimak appointed as the new Chief Financial Officer. This transition marks a pivotal moment for Cronos, poised to leverage Anna’s extensive experience within the...

Continue Reading
Investigation into Major Firms: Legal Rights for Shareholders

Updated Category News Views 325

Understanding the Recent Investigations Johnson Fistel, PLLP, a notable shareholder rights law firm, has initiated inquiries into potential legal violations involving several major corporations: Elanco Animal Health Incorporated (NYSE: ELAN), Masimo Corporation (NASDAQ: MASI), Fidelity National Information Services, Inc. (NYSE: FIS), and Super Micro Computer, Inc....

Continue Reading
Copa Holdings Reports Impressive Passenger Traffic Growth

Updated Category News Views 96

Overview of Copa Holdings' Monthly Performance Recently, Copa Holdings, S.A. (NYSE: CPA) shared its preliminary passenger traffic statistics for a noteworthy month. Following a trend of growth, these statistics for November highlight significant increases and operational achievements for the airline. Passenger Traffic Insights For November, Copa Holdings reported an...

Continue Reading
Cardinal Health Readies for Q4 Earnings: Market Insights Ahead

Updated Category News Views 151

Cardinal Health Prepares for Its Fourth Quarter Earnings Report Cardinal Health, Inc. (NASDAQ: CAH) is poised to announce its fourth quarter earnings, which is expected to generate significant attention from investors and analysts alike. The upcoming earnings report will provide insights into the company's performance over the past quarter, and many are curious to know...

Continue Reading